What is the main purpose of this 8-K filing?

This 8-K filing serves to announce Gilead Sciences' financial results for the quarter and six months ended June 30, 2017. It includes a press release that details the company's financial performance for the period.

Why does Gilead provide both GAAP and non-GAAP financial information?

Gilead provides non-GAAP financial information because management believes it offers a useful supplemental view of the company's operational performance. These metrics are used internally for strategic planning and budgeting and can help investors better understand the underlying business trends when viewed alongside GAAP results.

Where can I find a detailed breakdown of Gilead's financial results?

The detailed financial results, including a reconciliation between GAAP and non-GAAP measures, are provided in the press release filed as Exhibit 99.1 to this 8-K report. Investors should refer to this exhibit for comprehensive financial data.

Is the information in this filing legally considered 'filed' for Section 18 of the Exchange Act?

No, the information in this Form 8-K and its exhibit is explicitly stated as not being deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities under that section. It also will not be deemed incorporated by reference into any other filing under the Securities Act or the Exchange Act.

GILD 8-K: Earnings & Results

Summary

Gilead Sciences, Inc. (GILD) announced its financial results for the second quarter and first half of 2017 via a press release filed on July 26, 2017. The report highlights the company's performance for the periods ending June 30, 2017, and provides both GAAP and non-GAAP financial measures. Management emphasizes the usefulness of non-GAAP information for investors in understanding operational performance, as these metrics are used internally for strategic decision-making and financial planning. Investors should note that while the press release contains key financial data, it is important to review the provided reconciliations between GAAP and non-GAAP figures to fully grasp the company's financial position. The filing itself is an 8-K reporting a material event, specifically the release of quarterly earnings, and should be reviewed in conjunction with the detailed financial statements and disclosures contained within the referenced Exhibit 99.1.

Key Highlights

1Gilead Sciences announced its Q2 and H1 2017 financial results on July 26, 2017.
2The company provided both GAAP and non-GAAP financial information.
3Non-GAAP financial measures are presented to offer additional insights into operational performance.
4Management utilizes non-GAAP measures for internal operating, budgeting, and financial planning.
5A reconciliation between GAAP and non-GAAP financial information is available within the filed press release (Exhibit 99.1).
6The filing is an 8-K report detailing the results of operations and financial condition.

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Jul 26, 2017)

Summary

Key Highlights

Frequently Asked Questions